Discovery and characterization of potent and selective inhibitors to human epithelial 15-lipoxygenase-2

被引：0

作者：

Jameson, J. Brian, II ^{[2
]}

Kantz, Auric ^{[2
]}

Jadhav, Ajit ^{[1
]}

Simeonov, Anton ^{[1
]}

Maloney, David ^{[1
]}

Holman, Ted ^{[2
]}

机构：

[1] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA

[2] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA

来源：

FASEB JOURNAL | 2014年 / 28卷 / 01期

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

582.5

引用

页数：1

共 50 条

[31] O-PRENYLATED COUMARINS: POTENT HUMAN 15-LIPOXYGENASE-1 INHIBITORS
Sadeghian, H.
Jabbari, A.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 135 - 135
[32] Discovery of Potent and Selective Pyrazolopyrimidine Janus Kinase 2 Inhibitors
Hanan, Emily J.
van Abbema, Anne
Barrett, Kathy
Blair, Wade S.
Blaney, Jeff
Chang, Christine
Eigenbrot, Charles
Flynn, Sean
Gibbons, Paul
Hurley, Christopher A.
Kenny, Jane R.
Kulagowski, Janusz
Lee, Leslie
Magnuson, Steven R.
Morris, Claire
Murray, Jeremy
Pastor, Richard M.
Rawson, Tom
Siu, Michael
Ultsch, Mark
Zhou, Aihe
Sampath, Deepak
Lyssikatos, Joseph P.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 10090 - 10107
[33] 15-lipoxygenase-2 (15-LOX-2) is expressed in type II pneumocytes and lung adenocarcinomas
Gonzalez, AL
Roberts, RL
Johnson, JE
Olson, SJ
Shappell, SB
LABORATORY INVESTIGATION, 2002, 82 (01) : 320A - 320A
[34] Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1
Llona-Minguez, Sabin
Hoglund, Andreas
Jacques, Sylvain A.
Johanson, Lars
Calderon-Montano, Jose Manuel
Claesson, Magnus
Loseva, Olga
Valerie, Nicholas C. K.
Lundback, Thomas
Piedrafita, Javier
Maga, Giovanni
Crespan, Emmanuele
Meijer, Laurent
Moron, Estefania Burgos
Baranczewski, Pawel
Hagbjork, Ann-Louise
Svensson, Richard
Wiita, Elisee
Almlof, Ingrid
Visnes, Torkild
Jeppsson, Fredrik
Sigmundsson, Kristmundur
Jensen, Annika Jenmalm
Artursson, Per
Jemth, Ann-Sofie
Stenmark, Pal
Berglund, Ulrika Warpman
Scobie, Martin
Helleday, Thomas
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (03) : 1140 - 1148
[35] Discovery and characterization of novel, potent, and selective hypoxia-inducible factor (HIF)-2α inhibitors
Lawson, K.
Gauthier, K. Sivick
Piovesan, D.
Fournier, J.
Rosen, B.
Maliyan, A.
Beatty, J.
Jin, L.
Leleti, M.
Ginn, E.
Udyavar, A.
Ada, C.
Au, J.
Meleza, C.
Zhao, S.
Young, S.
Walters, M.
Powers, J.
EUROPEAN JOURNAL OF CANCER, 2020, 138 : S16 - S16
[36] 15-lipoxygenase-2 (15-LOX-2) is expressed in Type II pneumocytes and lung adenocarcinomas
Gonzalez, AL
Roberts, RL
Johnson, JE
Olson, SL
Shappell, SB
MODERN PATHOLOGY, 2002, 15 (01) : 320A - 320A
[37] The Discovery of Setileuton, a Potent and Selective 5-Lipoxygenase Inhibitor
Ducharme, Yves
Blouin, Marc
Brideau, Christine
Chateauneuf, Anne
Gareau, Yves
Grimm, Erich L.
Juteau, Helene
Laliberte, Sebastien
MacKay, Bruce
Masse, Frederic
Ouellet, Marc
Salem, Myriam
Styhler, Angela
Friesen, Richard W.
ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (04): : 170 - 174
[38] Role of Human 15-Lipoxygenase-2 in the Biosynthesis of the Lipoxin Intermediate, 5S,15S-diHpETE, Implicated with the Altered Positional Specificity of Human 15-Lipoxygenase-1
Perry, Steven C.
Horn, Thomas
Tourdot, Benjamin E.
Yamaguchi, Adriana
Kalyanaraman, Chakrapani
Conrad, William S.
Akinkugbe, Oluwayomi
Holinstat, Michael
Jacobson, Matthew P.
Holman, Theodore R.
BIOCHEMISTRY, 2020, 59 (42) : 4118 - 4130
[39] Structural Dynamics of 15-Lipoxygenase-2 via Hydrogen-Deuterium Exchange
Droege, Kristin D.
Keithly, Mary E.
Sanders, Charles R.
Armstrong, Richard N.
Thompson, Matthew K.
BIOCHEMISTRY, 2017, 56 (38) : 5065 - 5074
[40] Inhibition of Tumor Growth by 15-Lipoxygenase-2 through inactivation of PDGF pathway
Bai, Xiangyang
Wu, Hong
Wang, Dian
CANCER RESEARCH, 2009, 69

← 1 2 3 4 5 →